
Revvity Inc RVTY.N reported quarterly adjusted earnings of $1.01 per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of 98 cents. The mean expectation of nineteen analysts for the quarter was for earnings of 95 cents per share. Wall Street expected results to range from 93 cents to 98 cents per share.
Revenue rose 2.3% to $664.76 million from a year ago; analysts expected $661.18 million.
Revvity Inc's reported EPS for the quarter was 35 cents.
The company reported quarterly net income of $42.24 million.
Revvity Inc shares had fallen by 10.9% this quarter and lost 15.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 10.7% in the last three months.
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Revvity Inc is $128.50
This summary was machine generated from LSEG data April 28 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Mar. 31 2025 | 0.95 | 1.01 | Beat |
Dec. 31 2024 | 1.37 | 1.42 | Beat |
Sep. 30 2024 | 1.13 | 1.28 | Beat |
Jun. 30 2024 | 1.12 | 1.22 | Beat |